Results 71 to 80 of about 113,972 (304)
International Journal of Hepatology, 2013 Introduction. The role of hepatic resection in patients with liver metastases from gastroenteropancreatic neuroendocrine tumors (GEP-NETs) is still poorly defined. Therefore, we examined the results obtained with surgical resection and other locoregional
Stefano Bacchetti +4 more
doaj +1 more source
Liver Resection for Hepatic Adenoma [PDF]
, 1979 Between 1970 and 1978, eight hepatic adenomas were resected. Four of the eight patients took oral contraceptive pills before the hepatic adenoma was identified; one patient was male. Four patients had evidence of bleeding at the time of presentation. The
Koep, LJ +4 more
core +1 more source
Tumor‐Infiltrating mregDCs Restrain Anti‐Tumor Immunity in Early Relapse HCC
Advanced Science, EarlyView.Tumor‐infiltrating mregDCs are regulated by the TNFR2‐non‐canonical NF‐κB axis, which is mediated by TNF‐α secreted by CD161+CD8+ T cells. These mregDCs recruit CD161+CD8+ T cells via the CCL20‐CCR6 axis, forming a positive feedback loop that enhances immunosuppression, promotes early recurrence of HCC, and further confirms TNFR2 as a key therapeutic ...
Zefan Zhang +13 more
wiley +1 more source
Gastroenterology Research and Practice, 2015 This paper was designed to evaluate a novel surgical procedure of using a gastroduodenal artery graft for reconstruction of the hepatic artery during radical resection of hilar cholangiocarcinoma, which is citation-free and self-contained.
Yurong Liang +4 more
doaj +1 more source
Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer. [PDF]
, 2015 PURPOSE Surgical cytoreduction remains a cornerstone in the management of patients with advanced and recurrent epithelial ovarian cancer. Parenchymal liver metastases determine stage VI disease and are commonly considered a major limit in the ...
Mueller, Michael +23 more
core +1 more source
Advanced Science, EarlyView.SLC25A13 is identified as an immunometabolic driver of triple‐negative breast cancer that sustains ferroptosis resistance and immune evasion through a STAT3–IFI6 circuit. Pharmacologic degradation of SLC25A13 restores ferroptosis sensitivity and enhances anti‐PD‐1 efficacy, highlighting a strategy to convert immune‐cold tumors into immunotherapy ...
Yingze Zhu +8 more
wiley +1 more source
Il trattamento delle metastasi epatiche da cancro del coloretto [PDF]
, 2011 Il cancro del colon-retto (CRC) è il quarto cancro più comune in Occidente e la seconda causa più comune di mortalità per cancro dopo il tumore al polmone correlati in Europa e Nord America [1,2].
Scibelli, Tina
core
Enhanced Recovery Pathway after Hepatic Resection. [PDF]
, 2016 Enhanced Recovery Pathway after Hepatic Resection.
Victor Zaydfudim (3181296) +4 more
core +1 more source
PDIA6–SCD1 Axis Rewires Lipid Metabolism to Drive Gastric Cancer Progression
Advanced Science, EarlyView.Protein disulfide isomerase A6 (PDIA6) is identified as an oncogenic driver in gastric cancer. PDIA6 directly binds and stabilizes SCD1 by limiting its ubiquitin–proteasome‐mediated degradation, thereby sustaining monounsaturated fatty acid (MUFA)‐enriched lipid homeostasis and lipid metabolic reprogramming.
Zhen Tian +13 more
wiley +1 more source
Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma [PDF]
, 2015 Jian-Hong Zhong,1,2 Bang-De Xiang,1,2 Le-Qun Li1,2 1Hepatobiliary Surgery Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Guangxi Liver Cancer Diagnosis and Treatment Engineering and ...
Xiang BD, Li LQ, Zhong JH
core